COVID-19

In healthcare, inclusivity is not just a moral imperative, it is also a strategic necessity for achieving widespread immunity to infections and diseases, like COVID-19, and advancing public health outcomes.

The European Commission has granted a fifteen-month extension to continue with the RBDCOV Project. So far, 240 volunteers have been recruited across all the centres set to join adolescents’ clinical trial (named HH3) to test the efficacy,

ORCHESTRA opens doors to COVID-19 related data to selected scientists

Verona 17/07/2023 – ORCHESTRA-Cohort is a multinational cohort research project on COVID-19 and its long-term sequelae.

A large study on the effectiveness of the Pfizer-BioNTech’s Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine.

The study was conducted at Israel’s largest healthcare organization, 

Padua, 30 June 2022 – A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in 

One of the objective of RBDCOV is to test whether the vaccine can reactivate or re-generate a protective immune response against the virus

The RBDCOV project,

Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein.

Penta is proud to be a partner in the Horizon Europe funded “RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) project. Within the project we will be bringing our paediatric expertise and drive to improve health outcomes for children.

Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants

The University of Padua and Penta Foundation are leaders of VERDI,

A study published in the Pediatrics journal shows that children with mild forms of COVID-19 develop a greater and longer lasting antibody response than that of adults.

Università degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini

Uno studio pubblicato in questi giorni sulla rivista “Paediatrics” dimostra che i bambini affetti da forme lievi di COVID-19 sviluppano una risposta anticorpale maggiore e più duratura di quella degli adulti.

An Italian-led project supported by the UniCredit Foundation to study the impact of the coronavirus on children.

The project CORONA: children and COVID-19 has kicked off.

We recently met with Carlo Giaquinto – Penta President and Francesco Bonfante – Virologist at IZSVe to have some scientific opinion on Covid 19 testing.

In December 2020 Penta held its annual Scientific Meeting. Despite the unusual get together due to COVID-19, we shared great science together. Among the experts invited was Timo Vesikari, a vaccine specialist who provided an insightful overview of the current scenario around COVID-19 vaccine development.

Data gathered worldwide are increasingly suggesting that schools are not hotspots for coronavirus infections. Despite fears, COVID-19 infections did not surge when schools and day-care centres reopened after pandemic lockdowns eased.

Join this webinar, hosted by CHAI, to get highlights on key trends in the HIV space in LMICs from CHAI’s 2020 HIV Market Report.

You can expect an insightful panel discussion focusing on the resiliency of national HIV programs and markets and ensuring HIV care continuity during these trying times.

The COVID-19 pandemic is highlighting the importance of international collaboration, particularly in the field of health and science. Collaborative efforts between study leads, scientific societies and researchers has the potential to speed-up research.